abstract |
The present invention relates to the field of formulations, in particular to the treatment of neurodegenerative diseases. The present invention specifically relates to a family of compounds that have been shown to have neuroprotective activity. Since certain members of the family provide novel compounds that have not been described previously, the present invention relates to novel products, methods for their synthesis, and certain novel intermediate synthetic products. The invention further relates to the use of said compounds as a medicament for the manufacture of a composition comprising said family of compounds, in particular a medicament for the treatment of neurodegenerative diseases. |